Market Research Report
US Market for Orthopedic Soft Tissue and Sports Medicine 2011-2021
|Published by||iData Research Inc.||Product code||222447|
|Published||Content info||272 Pages
Delivery time: 1-2 business days
|US Market for Orthopedic Soft Tissue and Sports Medicine 2011-2021|
|Published: June 1, 2015||Content info: 272 Pages||
This publication has been discontinued on August 24, 2016.
The U.S. market for orthopedic soft tissue repair includes anterior and posterior cruciate ligament (ACL/PCL) reconstruction and fixation products, cartilage repair therapies, meniscal repair devices, rotator cuff repair devices, shoulder and labrum repair devices, rotator cuff graft reinforcement devices, hip arthroscopy devices and biceps tenodesis devices. These devices are used for closed technique treatments of worn or injured joints. The majority of such treatments are performed on knee and shoulder joints, although there is an increasing interest among the surgical community in hip and small joint arthroscopy.
The orthopedic soft tissue market consists of fixation devices for rotator cuff, shoulder labrum, ACL/PCL and meniscal repair, graft options for tendons and cartilage along with devices for hip arthroscopy. Procedures for such repairs continue to grow and, coupled with product innovation, will drive the market up in value. Many existing products including all-suture anchors, cortical fixation devices and hybrid meniscal repair devices have pushed market growth. New products such as cartilage repair products used with microfracture or synthetic tissue graft options for reinforcement or ACL/PCL replacement will continue to generate value in the marketplace. While the shift of many procedures, particularly arthroscopies, to ambulatory surgery centers applies some downwards pressure on prices; however, continuous product innovation will maintain average prices for the foreseeable future.